VISTAGEN THERAPEUTICS, INC. Non Peo Neo Avg Comp Actually Paid Amt
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Non Peo Neo Avg Comp Actually Paid Amt of $326.78 thousand for the 12-month period ending 2026-03-31, per its DEF 14A filed 2026-07-31.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:NonPeoNeoAvgCompActuallyPaidAmt · last filed 2026-07-31
| Period end | Non Peo Neo Avg Comp Actually Paid Amt 12 month |
|---|---|
| 2026-03-31 | $326.78K DEF 14A · filed 2026-07-31 |
| 2025-03-31 | $982.08K DEF 14A · filed 2026-07-31 |
| 2024-03-31 | $575.43K DEF 14A · filed 2026-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |